Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance

Inverse vaccines that tolerogenically target antigens to antigen-presenting cells (APCs) offer promise in prevention of immunity to allergens and protein drugs and treatment of autoimmunity. We have previously shown that targeting hepatic APCs through intravenous injection of synthetically glycosyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Maulloo, Chitavi D., Cao, Shijie, Watkins, Elyse A., Raczy, Michal M., Solanki, Ani. S., Nguyen, Mindy, Reda, Joseph W., Shim, Ha-Na, Wilson, D. Scott, Swartz, Melody A., Hubbell, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498032/
https://www.ncbi.nlm.nih.gov/pubmed/34630389
http://dx.doi.org/10.3389/fimmu.2021.714842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498032/
https://www.ncbi.nlm.nih.gov/pubmed/34630389
http://dx.doi.org/10.3389/fimmu.2021.714842

Ejemplares similares